DK162697C - Tabletter til langsom, nulte-ordens frigivelse via styret overfladeerosion - Google Patents

Tabletter til langsom, nulte-ordens frigivelse via styret overfladeerosion

Info

Publication number
DK162697C
DK162697C DK333884A DK333884A DK162697C DK 162697 C DK162697 C DK 162697C DK 333884 A DK333884 A DK 333884A DK 333884 A DK333884 A DK 333884A DK 162697 C DK162697 C DK 162697C
Authority
DK
Denmark
Prior art keywords
pharmaceutically acceptable
compound
oral compositions
compositions
range
Prior art date
Application number
DK333884A
Other languages
English (en)
Other versions
DK333884A (da
DK162697B (da
DK333884D0 (da
Inventor
David R Powell
Vithal K Patel
Original Assignee
Rowell Lab Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rowell Lab Inc filed Critical Rowell Lab Inc
Publication of DK333884D0 publication Critical patent/DK333884D0/da
Publication of DK333884A publication Critical patent/DK333884A/da
Publication of DK162697B publication Critical patent/DK162697B/da
Application granted granted Critical
Publication of DK162697C publication Critical patent/DK162697C/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Sliding Valves (AREA)
  • Electroplating Methods And Accessories (AREA)
  • Mechanical Treatment Of Semiconductor (AREA)
DK333884A 1983-07-07 1984-07-06 Tabletter til langsom, nulte-ordens frigivelse via styret overfladeerosion DK162697C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/511,605 US4539198A (en) 1983-07-07 1983-07-07 Solid pharmaceutical formulations for slow, zero order release via controlled surface erosion: expanded range
US51160583 1983-07-07

Publications (4)

Publication Number Publication Date
DK333884D0 DK333884D0 (da) 1984-07-06
DK333884A DK333884A (da) 1985-01-08
DK162697B DK162697B (da) 1991-12-02
DK162697C true DK162697C (da) 1992-04-21

Family

ID=24035636

Family Applications (1)

Application Number Title Priority Date Filing Date
DK333884A DK162697C (da) 1983-07-07 1984-07-06 Tabletter til langsom, nulte-ordens frigivelse via styret overfladeerosion

Country Status (14)

Country Link
US (1) US4539198A (da)
EP (1) EP0131485B1 (da)
AT (1) ATE55900T1 (da)
AU (1) AU561633B2 (da)
CA (1) CA1224417A (da)
DE (1) DE3483072D1 (da)
DK (1) DK162697C (da)
ES (1) ES534096A0 (da)
FI (1) FI842528A (da)
IL (1) IL72089A (da)
IT (1) IT1180193B (da)
NO (1) NO170753C (da)
NZ (1) NZ208393A (da)
ZA (1) ZA845208B (da)

Families Citing this family (72)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57500432A (da) * 1980-03-20 1982-03-11
US4960765A (en) * 1980-03-20 1990-10-02 Farmaceutisk Laboratorium Ferring A/S Pharmaceutical composition and method for the treatment of colitis ulcerosa and Crohn's disease by oral administration
US4690824A (en) * 1983-07-07 1987-09-01 Redi-Rowell, Inc. Solid pharmaceutical formulations for slow, zero order release via controlled surface erosion: expanded range
USRE33994E (en) * 1983-08-16 1992-07-14 Burroughs Wellcome Co. Pharmaceutical delivery system
GB8322007D0 (en) * 1983-08-16 1983-09-21 Wellcome Found Pharmaceutical delivery system
US4851229A (en) * 1983-12-01 1989-07-25 Alza Corporation Composition comprising a therapeutic agent and a modulating agent
US4751071A (en) * 1983-12-01 1988-06-14 Alza Corporation Composition comprising salbutamol
US4777049A (en) * 1983-12-01 1988-10-11 Alza Corporation Constant release system with pulsed release
DE3346571A1 (de) * 1983-12-23 1985-07-04 Bayer Ag, 5090 Leverkusen Oral retardierte acetylsalicylsaeureformulierungen
IT1206166B (it) * 1984-07-26 1989-04-14 Sigma Tau Ind Farmaceuti Dispositivo per rilasciare una sostanza in un fluido di dissoluzione con cinetica di ordine zero e procedimento per la sua preparazione
US4631305A (en) * 1985-03-22 1986-12-23 The Upjohn Company Polymeric material as a disintegrant in a compressed tablet
EP0272265B1 (de) * 1985-09-25 1991-05-22 Gergely, Gerhard, Dr. Zerfallstablette und verfahren zu ihrer herstellung
US4753801A (en) * 1985-10-25 1988-06-28 Eli Lilly And Company Sustained release tablets
AU607690B2 (en) * 1985-12-24 1991-03-14 Marion Laboratories, Inc. Use of synthetic sulfated saccharides to enhance wound healing
US6482516B1 (en) * 1993-07-20 2002-11-19 Banner Pharmacaps, Inc. Enrobed tablet
MX9300110A (es) * 1992-01-13 1994-07-29 Gerhard Gergely Preparacion farmaceutica en la forma de una tableta de efervescencia o de desintegracion o de un granulado de tipo instanteneo y procedimiento para su preparacion.
US6676967B1 (en) 1993-09-20 2004-01-13 Kos Pharmaceuticals, Inc. Methods for reducing flushing in individuals being treated with nicotinic acid for hyperlipidemia
US6129930A (en) 1993-09-20 2000-10-10 Bova; David J. Methods and sustained release nicotinic acid compositions for treating hyperlipidemia at night
US6818229B1 (en) 1993-09-20 2004-11-16 Kos Pharmaceuticals, Inc. Intermediate release nicotinic acid compositions for treating hyperlipidemia
US6746691B2 (en) 1993-09-20 2004-06-08 Kos Pharmaceuticals, Inc. Intermediate release nicotinic acid compositions for treating hyperlipidemia having unique biopharmaceutical characteristics
US6080428A (en) 1993-09-20 2000-06-27 Bova; David J. Nicotinic acid compositions for treating hyperlipidemia and related methods therefor
US5609883A (en) * 1994-09-16 1997-03-11 Advanced Technology Pharmaceuticals Corporation Compressed tablet transitory lubricant system
HUP0104606A3 (en) * 1998-12-18 2003-01-28 Basf Ag A pharmaceutical mixture comprising a profen
US6726929B1 (en) 1998-12-18 2004-04-27 Basf Aktiengesellschaft Pharmaceutical mixture comprising a profen
US6210716B1 (en) 1999-02-26 2001-04-03 Andrx Pharmaceuticals, Inc. Controlled release bupropion formulation
US8545880B2 (en) * 1999-02-26 2013-10-01 Andrx Pharmaceuticals, Llc Controlled release oral dosage form
NZ517466A (en) 1999-09-02 2003-11-28 Nostrum Pharmaceuticals Inc Controlled release oral dosage suitable for oral administration
US6733780B1 (en) 1999-10-19 2004-05-11 Genzyme Corporation Direct compression polymer tablet core
US8088060B2 (en) 2000-03-15 2012-01-03 Orbusneich Medical, Inc. Progenitor endothelial cell capturing with a drug eluting implantable medical device
US9522217B2 (en) 2000-03-15 2016-12-20 Orbusneich Medical, Inc. Medical device with coating for capturing genetically-altered cells and methods for using same
AU8531101A (en) 2000-08-29 2002-03-13 Nobex Corp Immunoregulatory compounds and derivatives and methods of treating diseases therewith
CA2359812C (en) 2000-11-20 2004-02-10 The Procter & Gamble Company Pharmaceutical dosage form with multiple coatings for reduced impact of coating fractures
US20030032675A1 (en) * 2001-02-15 2003-02-13 Franz G. Andrew Manufacture of thyroid hormone tablets having consistent active moiety amounts
US20030224047A1 (en) * 2001-02-15 2003-12-04 Franz G. Andrew Levothyroxine compositions and methods
US6555581B1 (en) 2001-02-15 2003-04-29 Jones Pharma, Inc. Levothyroxine compositions and methods
KR20040100835A (ko) * 2001-02-15 2004-12-02 킹 파머슈티칼스 리서치 앤드 디벨로프먼트 아이엔씨 안정된 제약및 갑상선 내분비 호르몬 구성물 및 그제조방법
US20030180353A1 (en) * 2001-08-10 2003-09-25 Franz G. Andrew Stabilized pharmaceutical compositions
US20030190349A1 (en) * 2001-08-10 2003-10-09 Franz G. Andrew Methods of stabilizing pharmaceutical compositions
US20030198671A1 (en) * 2001-08-10 2003-10-23 Franz G. Andrew Levothyroxine compositions having unique plasma AUC properties
US20030198667A1 (en) * 2001-08-10 2003-10-23 Franz Andrew G. Methods of producing dispersible pharmaceutical compositions
US20030203967A1 (en) * 2001-08-14 2003-10-30 Franz G. Andrew Levothyroxine compositions having unique Tmax properties
US20030199586A1 (en) * 2001-08-14 2003-10-23 Franz G. Andrew Unique levothyroxine aqueous materials
US20030198672A1 (en) * 2001-08-14 2003-10-23 Franz G. Andrew Levothyroxine compositions having unique triidothyronine plasma AUC properties
US7101569B2 (en) 2001-08-14 2006-09-05 Franz G Andrew Methods of administering levothyroxine pharmaceutical compositions
US20030195253A1 (en) * 2001-08-14 2003-10-16 Franz G. Andrew Unadsorbed levothyroxine pharmaceutical compositions, methods of making and methods of administration
US20030199587A1 (en) * 2001-08-14 2003-10-23 Franz G. Andrew Levothyroxine compositions having unique Cmax properties
US8048924B2 (en) 2001-08-29 2011-11-01 Biocon Limited Methods and compositions employing 4-aminophenylacetic acid compounds
US20030175337A1 (en) * 2001-10-29 2003-09-18 Franz G. Andrew Levothyroxine compositions having unique triiodothyronine Tmax properties
US6893660B2 (en) * 2002-11-21 2005-05-17 Andrx Pharmaceuticals, Inc. Stable pharmaceutical compositions without a stabilizer
CN1980576B (zh) 2004-07-02 2012-07-18 株式会社明治 固体乳及其制备方法
DK1773767T3 (da) 2004-07-07 2016-03-21 Biocon Ltd Syntese af azo-bundne immunregulerende forbindelser
KR20080085924A (ko) * 2004-09-01 2008-09-24 더 프록터 앤드 갬블 캄파니 5-아미노-2-하이드록시벤조산 및 환원당을 함유하는 조성물
US7985418B2 (en) * 2004-11-01 2011-07-26 Genzyme Corporation Aliphatic amine polymer salts for tableting
JP2009507019A (ja) 2005-09-02 2009-02-19 ジェンザイム・コーポレーション リン酸塩を除去する方法およびそれに使用される重合体
DK1924246T3 (da) 2005-09-15 2016-01-18 Genzyme Corp Portionsbrevformulering til aminpolymerer
US8497258B2 (en) 2005-11-12 2013-07-30 The Regents Of The University Of California Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract
US20110165236A1 (en) * 2006-09-22 2011-07-07 Biokey, Inc. Controlled release hydrogel formulation
US20080075785A1 (en) * 2006-09-22 2008-03-27 San-Laung Chow Controlled release hydrogel formulation
EP2066293A2 (en) 2006-09-29 2009-06-10 Genzyme Corporation Amide dendrimer compositions
BRPI0720234A2 (pt) 2006-12-14 2013-12-24 Genzyme Corp Composição farmacêutica
US20090036414A1 (en) * 2007-08-02 2009-02-05 Mutual Pharmaceutical Company, Inc. Mesalamine Formulations
WO2009064819A2 (en) 2007-11-13 2009-05-22 Meritage Pharma, Inc. Compositions for the treatment of gastrointestinal inflammation
US20100316589A1 (en) * 2007-12-14 2010-12-16 Hitesh Bhagat Coated Pharmaceutical Compositions
EP2329823A4 (en) * 2008-09-03 2013-04-03 Takeda Pharmaceutical METHOD FOR IMPROVING CAPACITY OF PREPARATION TO BE ABSORBED AND PREPARATION WHICH CAPACITY TO BE ABSORBED IS IMPROVED
US20110097401A1 (en) 2009-06-12 2011-04-28 Meritage Pharma, Inc. Methods for treating gastrointestinal disorders
RU2593771C2 (ru) 2010-04-30 2016-08-10 Такеда Фармасьютикал Компани Лимитед Энтеросолюбильная таблетка
EA030433B1 (ru) 2010-04-30 2018-08-31 Такеда Фармасьютикал Компани Лимитед Энтеросолюбильная таблетка
DE102010033527A1 (de) 2010-08-05 2012-02-09 Acino Pharma Ag Quetiapin-Tabletten
EP2425826A1 (en) 2010-09-01 2012-03-07 Disphar International B.V. Mesalazine tablet having improved dissolution
DE102011115690A1 (de) 2011-10-11 2013-04-11 Acino Pharma Ag Quetiapin enthaltende Formulierungen
ITUA20162293A1 (it) 2016-04-05 2017-10-05 Sofar Spa Processo per formulazioni solide di mesalazina
EP3662898A1 (en) * 2018-12-07 2020-06-10 Tillotts Pharma AG Solid composition comprising mesalazine

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4361545A (en) * 1979-05-21 1982-11-30 Rowell Laboratories, Inc. Solid pharmaceutical formulations for slow, zero order release via controlled surface erosion
US4264573A (en) * 1979-05-21 1981-04-28 Rowell Laboratories, Inc. Pharmaceutical formulation for slow release via controlled surface erosion
FR2471186A1 (fr) * 1979-12-10 1981-06-19 Roussel Uclaf Nouveaux comprimes a delitescence colique, ainsi que leur procede de preparation
JPS57500432A (da) * 1980-03-20 1982-03-11

Also Published As

Publication number Publication date
ES8600053A1 (es) 1985-10-01
ES534096A0 (es) 1985-10-01
AU561633B2 (en) 1987-05-14
ZA845208B (en) 1985-03-27
IL72089A0 (en) 1984-10-31
FI842528A (fi) 1985-01-08
IT8421720A1 (it) 1986-01-02
DK333884A (da) 1985-01-08
IT8421720A0 (it) 1984-07-02
NZ208393A (en) 1987-03-31
CA1224417A (en) 1987-07-21
US4539198A (en) 1985-09-03
IL72089A (en) 1987-09-16
EP0131485B1 (en) 1990-08-29
DK162697B (da) 1991-12-02
AU2889884A (en) 1985-01-10
NO170753B (no) 1992-08-24
DK333884D0 (da) 1984-07-06
DE3483072D1 (de) 1990-10-04
NO170753C (no) 1992-12-02
IT1180193B (it) 1987-09-23
EP0131485A2 (en) 1985-01-16
NO842766L (no) 1985-01-08
FI842528A0 (fi) 1984-06-21
ATE55900T1 (de) 1990-09-15
EP0131485A3 (en) 1986-08-06

Similar Documents

Publication Publication Date Title
DK162697C (da) Tabletter til langsom, nulte-ordens frigivelse via styret overfladeerosion
RS49606B (sr) Farmaceutski preparat derivata n- piperidino-3- pirazolkarboksamida, njegovih soli i njihovih solvata za oralnu administraciju
NO981027L (no) Bioadhesiv fast doseringsform
UY24386A1 (es) Nuevos taxoides, su preparación y composiciones farmacéuticas que los contienen.
IT1282352B1 (it) Composizione farmaceutica, in particolare essiccata mediante congelamento, per somministrazione orale di ondansetron e metodo per
PL315636A1 (en) Cosmetic or pharmaceutic compositions containing magnipherine or its derivatives
FI945081A (fi) Stabiili hydratoitu kefalosporiinikuivajauhe oraaliseen suspensioformulaatioon
CA2136404A1 (fr) Composition solide mucoadhesive, therapeutique ou hygienique, pour administration par application sur la muqueuse buccale ou nasale
HUP0103431A2 (hu) 5-HT4 receptor agonista vagy antagonista hatóanyagot tartalmazó, orális gyógyászati készítmény
FI921809A (fi) Foerfarande foer framstaellning av en tablett- eller dragekomposition, som innehaoller en foer vaerme, ljus och fuktighetkaenslig aktiv ingrediens med monoklinisk kristallstruktur.
FI850828A0 (fi) Nya (8s)-8 -fluoroerytromycinderivat, foerfarande foer framstaellning av dessa och farmaceutiska sammansaettningar innehaollande dem.
NZ332655A (en) Pharmaceutical compositions containing diclofenac and alkali metal bicarbonates
DE69317418T2 (de) PHARMAZEUTISCHE ZUSAMMENSETZUNGEN VON 5HT1 AGONISTISCHEN ALKYL SULPHONAMIDENFüR REKTALE VERABREICHUNGEN
FR2719771B1 (fr) Compositions pharmaceutiques contenant du gemfibrozil.
TH59782A3 (th) สารผสมของกาแลนแทมีนชนิดปลดปล่อยที่มีการควบคุม
JO1653B1 (en) The current benzimidazole is a therapeutically active method for preparing it

Legal Events

Date Code Title Description
PBP Patent lapsed